NCT07642752 Perturbation Training vs Functional Activities on Pain, ROM, Balance, and Function Post-ACL
| NCT ID | NCT07642752 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2026-08-01 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anterior cruciate ligament (ACL) injuries are among the most common and functionally disabling knee injuries, particularly in physically active individuals. Despite advancements in surgical techniques, optimal post-operative rehabilitation remains critical for successful functional recovery, minimizing re-injury risk, and restoring pre-injury performance levels
Eligibility Criteria
Inclusion Criteria: * Age range: 18-45 years * Male participants only * History of Anterior Cruciate Ligament Reconstruction (ACLR) of 3 to 12 months * No prior ACL surgery on the affected knee * ACL reconstruction with autograft of hamstrings tendon * Knee flexion range of motion less than 120° * Extension lag less than or equal to 10° * Pain during functional activities Exclusion Criteria: * Any type of fracture * Concurrent ligamentous injury or repairable meniscus * Osteochondral defect * Any systemic and/or neurological illness * Rheumatoid arthritis * Osteomyelitis or any neurological disorders * Spinal disorders * Inflammatory conditions such as ankylosing spondylitis
Contact & Investigator
Hira Shaukat, Mphill
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07642752 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642752 currently recruiting?
Yes, NCT07642752 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07642752 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07642752 clinical trial?
NCT07642752 is sponsored by Riphah International University. The principal investigator is Hira Shaukat, Mphill at Riphah International University. The trial plans to enroll 54 participants.